MedPath

Effect of Rose oil on Gastro-esophageal Reflux Disease in comparison with omeprazole capsule

Phase 3
Conditions
Gastro-esophageal reflux disease.
Gastro-oesophageal reflux disease
Registration Number
IRCT2014101119489N1
Lead Sponsor
Tehran University of Medical Sciences, Vice chancellor for research and technology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Patients between 16 to 80 years old; Patients have at least 12 weeks history of GERD; No history of barrett's esophagus; No history of surgery on esophagus or stomach; No history of any cancer in esophagus, stomach or abdomen; No coagulation problem unable to withdrawal of drugs; No use of glucocorticoids and NSAIDs more than 3 days a week during last 28 days; No sucralfate use during 3 days before study; No aspirin use more than 150 mg daily; No active peptic ulcer or its complications; No antibiotic use for H. pylori eradication during last 28 days; No Cigarette smoking or alcohol drinking; Absence of any GERD complication.
Exclusion criteria:
Appearance of drug adverse effects; Loss of patient compliance

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umbers of regurgitation episodes. Timepoint: Onset of intervention and 10 and 20 days later. Method of measurement: History taking.;Numbers of heartburn episodes. Timepoint: Onset of intervention and 10 and 20 days later. Method of measurement: History taking.;Severity of regurgitations. Timepoint: Onset of intervention and twice 10 and 20 days later. Method of measurement: History taking.;Severity of heartburns. Timepoint: Onset of intervention and 10 and 20 days later. Method of measurement: History taking.
Secondary Outcome Measures
NameTimeMethod
Age. Timepoint: at the beginning of the survey. Method of measurement: ID information.;Sex. Timepoint: at the beginning of the survey. Method of measurement: inspection.;Duration of drug use. Timepoint: In 10 days intervals. Method of measurement: Patient statements.;Side effects. Timepoint: Twice in 10-day intervals. Method of measurement: History and physical exams.
© Copyright 2025. All Rights Reserved by MedPath